Learning Objectives:

1.  Highlight novel insights and therapeutic approaches for idopathic, multicentric Castleman disease and other cytokine storm disorders.

2.  Discuss the potential for drug repurposing to address conditions without available treatment options including -7,000 rare diseases.

3.